Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Selecting Patients for AF Ablation in Heart Failure
Author(s): Aaron A Sifuentes , Mohammed Mhanna , Paari Dominic , et al Added: 1 month ago

Demographic

Electrophysiology & Arrhythmia
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
Added: 3 months ago Source:  CFR Journal Radcliffe Cardiology
A prespecified, secondary analysis of the MAPLE-HCM trial has shown that aficamten monotherapy provides superior and rapid benefits across multiple domains of disease burden compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).¹ Aficamten is a next-in-class cardiac myosin inhibitor (CMI) designed to reduce myocardial hypercontractility by decreasing… View more

Heart Failure